Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$0.474 -8.16%
Market Cap
$14.4M
Price Target
Refer to Report
Volume
2.0M
52wk Range
$0.25 - $3.6499
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.